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HeLa cells treated with human lymphoblastoid interferon do not synthesize poliovirus proteins. The anti- 
viral state against poliovirus is reversed if cells are previously infected with adenovirus type 5. A late gene 
product seems to be involved in this reversion, since no effect is observed at early stages of infection or 
in the presence of aphidicolin. 
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1. INTRODUCTION 
Animal cells treated with homologous interferon 
do not allow the growth of a number of viruses [ 11. 
The molecular basis of the so-called antiviral state 
is still poorly understood [2,3]. However, a 
number of new proteins, that appear as a conse- 
quence of interferon treatment, can be identified 
by methods such as 2-D gel electrophoresis [4-61. 
Amongst these induced proteins are a 2 ’ -5 ’ -A syn- 
thetase and a protein kinase able to phosphorylate 
eIF2, upon dsRNA stimulation [l-3]. Activation 
of one of these enzyme activities after viral infec- 
tion blocks viral translation [ 1,2]. However, not all 
animal viruses are equally sensitive to interferon 
[7]. For example, vaccinia virus grows in several 
cell lines treated with interferon [7]. Furthermore, 
translation of vaccinia mRNAs takes place in 
interferon-treated cells at control levels. Moreover, 
vaccinia virus infection reverses the antiviral state 
established by interferon in some cell lines by 
abolishing its inhibitory effects on translation of 
several RNA-containing viruses, such as vesicular 
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stomatitis virus and poliovirus [8-l 11. This effect 
is dependent on early gene expression by the vac- 
cinia virus [9,1 l] and most likely involves inhibi- 
tion of the IFN-induced dsRNA-dependent protein 
kinase by an early viral polypeptide [ 10-131. The 
2 ’ -5 ‘A synthetase activity was reported to be inac- 
tivated by vaccinia virus through two viral-me- 
diated enzyme activities: an ATPase that degrades 
ATP and a phosphatase that dephosphorylates 
ppp(A2’p)nA [11,14]. In contrast, high levels of 
2 ’ -5 ‘A derivatives are found in vaccinia virus- 
infected cells, irrespective of whether they are 
pretreated with interferon or not [ 151. A complex 
mixture of authentic 2’-5’A plus non-phospho- 
rylated cores (A2’p)nA and additional non- iden- 
tified compounds are synthesized in vaccinia virus- 
infected cells treated with interferon [16]. This 
mixture activates the 2’-S’ A-dependent RNase, at 
least in cell-free systems [13]. Therefore, the 
2’ -5 ‘A synthetase and RNase L activities are 
present in the infected cells, but vaccinia virus can 
interfere with the antiviral action of interferon by 
modifying the authentic 2’-5’A. In this manner, 
the RNase L present in the cell will not be activated 
by the modified 2’-5’A [16]. 
The synthesis of proteins in some other virus- 
infected animal cells is also unaffected by in- 
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terferon [7,17-191. Adenovirus and reovirus infec- 
tion of HeLa cells treated with interferon are 
examples [ 1,191. Reovirus infection does not 
reverse the antiviral state when cells are 
superinfected with VSV or poliovirus [1,17]. 
However, in this report we show that adenovirus 
infection does reverse the antiviral state established 
by interferon and that this reversion is most 
probably a late function. 
2. MATERIALS AND METHODS 
2.1. Cells and virus 
HeLa and Vero cells were grown in culture Petri 
dishes (Falcon Plastics) containing 10 ml of 
Dulbecco’s modified Eagle’s medium (E4D) sup- 
plemented with 10% calf serum (Gibco) and in- 
cubated at 37°C in a 5% CO2 atmosphere. 
Poliovirus type 1 (Mahoney strain), adenovirus 
type 5 and vaccinia virus were grown on HeLa cells 
in E4D medium supplemented with 2% calf serum. 
Herpes simplex virus type 1 was grown on Vero 
cells in the same medium. In all cases, the fraction 
obtained after removal of cell debris by low-speed 
centrifugation was used as the source of virus. The 
concentration of virus was estimated by plaque 
assay. 
2.2. Conditions of infection 
HeLa cells grown in 96-well Linbro dishes were 
infected with virus at the m.o.i. indicated for each 
experiment in section 3. After 1 h of incubation at 
37°C the medium was removed and 50 ~1 of E4D2 
were added. The time of virus addition was con- 
sidered as - 1 h and zero time was taken as the 
point when the virus was removed. Incubation at 
37°C was continued until the initiation of 
radiolabelled protein synthesis. 
2.3. Analysis of proteins by polyacrylamide gel 
electrophoresis (SDS-PAGE) 
At the times after infection indicated in section 
3, 50 ~1 of methionine-free medium and 1.25 &i 
of [35S]methionine (1.45 Ci/mmol; Amersham) 
were added to the cells which were then incubated 
for 1 h. The radiolabelled cell monolayers were 
washed with PBS and dissolved in 50 pl of sample 
buffer (62.5 mM Tris, pH 6.8, 2% SDS, 0.1 M 
dithiothreitol, 17% glycerol and 0.024% 
bromophenol blue as indicator). Samples were 
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heated at 90°C for 5 min, and 10 ~1 were applied 
to a 15% polyacrylamide gel and run overnight at 
100 V/20 cm. Fluorography was carried out with 
20% (w/w) 2,5-diphenyloxazole in dimethyl 
sulfoxide. The gels were dried and exposed as 
described [20]. 
Densitometric profiles of the gel were obtained 
using a Chromoscan 3 (Joyce Loebl) microden- 
sitometer. 
2.4. Interferon 
Human lymphoblastoid interferon Hu-IFN- 
(Ly) at 1.7 x lo6 U/ml was a generous gift from 
Dr Finter (Wellcome Research Laboratories, 
England). 
3. RESULTS 
HeLa cells treated with human lymphoblastoid 
interferon do not support the growth of poliovirus 
and, as a result, viral protein synthesis is severely 
impaired [21]. In agreement with previous results 
[8,11,12], we found that infection of these cells 
with vaccinia virus reversed the blockade of 
poliovirus replication by interferon (fig. 1). 
Therefore, poliovirus protein synthesis occurred to 
MoRATti 
Fig.1. Effect of interferon treatment on protein 
synthesis inHeLa cells doubly infected with vaccinia nd 
poliovirus. Cells grown in 96-well Linbro dishes were 
treated with 400 W/ml of Hu-IFN (Ly) 18 h before 
vaccinia infection. Poliovirus was added 3 h after 
infection with vaccinia. Cells were labelled with 
[35S]methionine and processed as indicated in section 2. 
The densitometric profiles of the proteins synthesized at 
4 h p.i. with poliovirus in single-infected or double- 
infected cells are shown. Cellular actin (AC) and 
polypeptides of viral origin are indicated. 
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the same extent in vaccinia-infected HeLa cells ir- 
respective of whether they had been pretreated 
with human lymphoblastoid interferon or not 
(fig.1). To determine whether this reversion also 
occurred upon infection with other DNA- 
containing viruses, HeLa cells treated with in- 
terferon were infected with adenovirus type 5 and, 
after 24 h of infection, they were superinfected 
with poliovirus. Fig.2 shows that, in agreement 
with previous work [21], poliovirus protein syn- 
thesis was inhibited by interferon, whereas 
adenovirus proteins were synthesized at control 
levels. Strikingly, if interferon-treated cells syn- 
thesizing adenovirus late. proteins were superin- 
fected with poliovirus, the synthesis of poliovirus 
proteins was observed (fig.2). Similar results were 
found when the superinfection was carried out 
with VSV (not shown). To determine whether the 
expression of an early virus product was responsi- 
ble for this reversion, HeLa cells, treated with in- 
terferon and infected with adenovirus, were 
superinfected with poliovirus after either 2 or 5 h 
of adenovirus infection. No reversion was found 
under these conditions as measured by the ap- 
pearance of poliovirus proteins (fig.3). Further- 
more, adenovirus-infected cells treated with 
15 pg/ml aphidicolin, a known inhibitor of DNA 
polymerase [22,23] became superinfected with 
poliovirus after 16 h. Again, no reversion was ob- 
tained in the presence of aphidicolin (not shown). 
These results point to an adenovirus late function 
being responsible for the reversion of the antiviral 
state. Herpesviruses are able to express their pro- 
teins in interferon-treated human cells [l&24,25]. 
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Fig.2. Effect of interferon treatment on protein synthesis in HeLa cells infected with adenovirus and superinfected with 
poliovirus. Cells grown in 96-well Linbro dishes were treated with 400 IU/ml Hu-IFN- (Ly) 18 h before infection with 
adenovirus (HPFU/cell). Cells were superinfected with poliovirus 24 h after adenovirus infection. They were then 
labelled with [35S]methionine and proteins analyzed as described in section 2. 
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Fig.3. Effect of interferon treatment on protein 
synthesis in HeLa cells superinfected with poliovirus at 
early stages of adenovirus infection. Cells grown in 
96-well Linbro dishes were treated with IFN 18 h before 
infection with adenovirus. Cells were superinfected with 
poliovirus at the indicated times. Proteins were labelled 
and analyzed as described in section 2. 
Interestingly, we found that HSV-1 infection also 
allowed poliovirus proteins to be synthesized in 
such cells (fig.4). The mechanism(s) triggered by 
each of these viruses to permit poliovirus protein 
synthesis remains to be elucidated. Perhaps 
adenovirus now represents the simplest model to 
identify the gene products involved in this 
phenomenon since it produces far fewer proteins 
than vaccinia and a number of mutants are 
available. 
4. DISCUSSION 
The elucidation of the interferon-induced an- 
tiviral state at the molecular level may be aided by 
the availability of new ways to block or reverse it. 
Since several DNA-containing viruses are able to 
overcome the antiviral state a detailed knowledge 
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Fig.4. Effect of interferon on protein synthesis in cells 
infected with HSV-1 and superinfected with poliovirus. 
Cells were grown in 96-well Linbro dishes and treated 
with 400 III/ml of Hu-IFN- (Ly) 12 h before the 
infection with HSV-1 (5 pfu/cell). They were 
superinfected with poliovirus (10 pfu/cell) at 10 h after 
HSV-1 infection. Proteins were labelled and analyzed as 
described in section 2. 
of the mechanisms involved would give new in- 
sights into the molecular basis of interferon action 
against viruses. The mechanisms used by vaccinia 
virus to avoid the antiviral effects of interferon are 
mainly based on the inhibition of the DAI-protein 
kinase [lo-131. Evidence that adenovirus can also 
block the DAI-protein kinase has accumulated in 
recent years. Adenoviruses express two small 
RNAs late in infection known as VA RNAs [26]. 
156 
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VA1 RNA is expressed in far larger quantities than 
VA11 RNA. Mutants unable to express VA1 RNA 
grow poorly and do not synthesize late viral pro- 
teins in spite of the fact that the mRNAs are pre- 
sent [27]. This translational defect has been 
correlated with the ability of VA1 RNA to block 
the DAI-protein kinase activity induced after in- 
terferon treatment [28,29]. Our findings showing 
the ability of poliovirus to synthesize proteins in 
adenovirus-infected cells treated with interferon 
could be consistent with this idea, since they can be 
interpreted as an adenovirus blockade of the DAI- 
protein kinase by means of VA1 RNA [29]. 
However, additional experiments on poliovirus 
superinfection of VA1 RNA( - ) mutants in cells 
treated with interferon would be necessary to con- 
firm the model proposed by these authors. As 
regards herpesvirus, human cells infected with 
HSVl or HSV2 contain high quantities of authen- 
tic 2’-5 ‘A, together with other potentially in- 
hibitory derivatives [24]. The synthesis of these 
compounds which interfere with the 2’-5 ‘A- 
dependent RNase, may explain the reversion we 
have found. The situation for herpesviruses will be 
similar to that for vaccinia virus, i.e. the RNase L 
present in the cell will not become activated by the 
virus-modified 2’ -5 ’ A 1241. 
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